Crystal structures of 1-(2-hydroxyphenyl)-3-phenyl-1,3-propanedione and 1-(1,3-benzodioxol-5-yl)-3-(2,4-dimethoxyphenyl)-1,3-propanedione

1-(2-Hydroxyphenyl)-3-phenyl-1,3-propanedione crystallizes in the triclinic space group (a=5.4233(5),b=13.910(1),c=17.036(1) Å, =68.311(6), =80.854(7), =78.760(8)°) as two independent enolic tautomers in which the hydroxyl and phenolic protons are hydrogen bonded to the ketonic oxygen atom. The structure was refined toR=0.039 for 2085I3(I) reflections. 1-(1,3-Benzodioxol-5-yl)-3-(2,4-dimethoxyphenyl)-1,3-propanedione, which belongs to the triclinic space group (a=7.3990(7),b=8.1239(5),c=14.004(1) Å, =86.673(6). =88.574(7), =64.885(7)°) also exists in the enolic form. The structure was refined toR=0.040 for 1564I3(I) reflections.     

Crystal structures of two modifications oftrans-1,3-bis(3,4-dimethoxyphenyl)-2,3-epoxy-1-propanone

trans-1,3-Bis(3,4-dimethoxyphenyl)-2,3-epoxy-1-propanone exhibits dimorphism and crystallizes in a monoclinic form from ethanol and in a trigonal form from chloroform/hexane. The crystal structures of the two modifications were determined by single-crystal X-ray diffraction methods. The monoclinic form crystallizes in space groupP2_t/c with ,b=7.986(1),c=25.223(4) , =94.83(2)°,V=1747.9(6) andZ=4.R=0.052 for 1236 reflections [I>3(I)]. The trigonal form crystallizes in space group witha=36.048(6),c=8.313(5) ,V=9355(6) andZ=18 (hexagonal axes).R=0.101 for 1216 reflections [I>3(I)]. In the trigonal crystals there are channels in thec-direction with a diameter of approximately 10 . Possible explanations for the comparatively highR-value are discussed.     

Structure of 593-1593-1593-1hexafluorophosphate, [Co(C5H4COOMe)2](PF6)

Crystals of [Co(C₅H₄COOMe)₂](PF₆) are triclinic, spacegroup witha=6.854(3),b=7.367(4),c=9.430(4) Å, =69.12(3), =86.56(4), =67.20(4)°,Z=1. The cation and anion both lie on crystal inversion centers. The Co–C bond lengths are in the range 2.030–2.041(3) Å. The COOMe groups are twisted 5.4° from the cyclopentadienyl ring planes. Refinement with 1574 data [I>3(I)] converged atR 0.041.     

Crystal and molecular structure of dimethylpyridazino[2,3-b]benzo-1,2,4-triazine-3,4-dicarboxylate radical,C14H11N4O4

The crystal and molecular structure of dimethylpyridazino[2,3-b]benzo-1,2,4-triazine-3,4-dicarboxylate radical, C₁₄H₁₁N₄O₄, has been determined from X-ray diffractometer data by direct methods and refined by least-squares methods toR=0.040 for 590 observed reflections. Crystals of C₁₄H₁₁N₄O₄ are monoclinic:a=9.222 (7),b=15.335(10),c=9.544(2) Å,=102.18(2)),Z=4, space groupP2₁/c. Bond distances and internal angles in the ring system have average values:C-C 1.387, C-N 1.358, and N-N 1.356 Å, and C--C 121.5, C--N 120.4, C- -C 117.8, N- -N 121.4, and N- -N 119.8°, respectively. All these bonds have a partial double-bond character, consistent with an extensive conjugation within the molecule, thus giving stability to the free radical. The condensed rings are nonplanar. The carbomethoxy groups show a different slant, owing to overcrowding.     

Crystal and molecular structure of palladium(II), copper(II) and zinc(II) complexes of 1-methyl-3-(4-methyl)phenyltriazen-1-oxide

The structures of palladium(II), copper(II) and zinc(II) bis(chelates) of 1-methyl-3-(4-methyl)phenyltriazen-1-oxide have been determined by single-crystal X-ray methods. The crystals of [Pd(OMeN₃C₆H₄Me-4)₂] (I) are triclinic witha=7.410(3),b=7.806(3),c=8.371(2) Å, =65.80(2), =88.73(3), =81.04(3)°,Z=1, space group . The crystals of [Cu(OMeN₃C₆H₄Me-4)₂] (II) are monoclinic,a=14.934(5),b=10.111(4),c=11.762(3) Å, =96.00(2)°,Z=4, space group P2₁/c. The crystals of [Zn(OMeN₃C₆H₄Me-4)₂] (III) are triclinic witha=7.912(2),b=10.056(2),c=11.600(2) Å, =87.31(3), =74.96(3), =74.02(3)°,Z=2, space group . The structures of (I), (II), and (III) were solved to final values ofR=0.029, 0.043 and 0.034, respectively. A planar structure has been found for (I), (II) exhibits a tetrahedrally distorted square planar structure, whereas (III) is tetrahedral. The crystals of all three complexes are held by networks of stacking interactions.     

X-ray crystal structure oftrans-dichlorobis(2,6-lutidine)palladium(II)

The X-ray structure oftrans-(2,6-lutidine)₂PdCl₂ has been determined. Golden orange crystals of the complex crystallize in the triclinic space group , with cell dimensionsa=7.6950(8),b=7.9705(10),c=8.0485(8)Å, =116.967(9), =113.343(8), and =93.836(9)°;V=385.18(7)ų andZ=2. 1336 unique reflections withI _net>3 (I) on refinement afforded values ofR=0.018 andR _w=0.023.     

Crystal structures of 3-[1-Benzenesulfonyl-3-phenylsulfanyl-1H-indol-2-yl]-1-[4-(methyl (I)/methoxy (II) phenyl)]-2-phenyl-propane-1-one

The compounds 3-(1-Benzenesulfonyl-3-phenylsulfanyl-1H-indol-2-yl)-1-[4-methyl (I)/methoxy (II)phenyl)]-2-phenyl-propane-1-one crystallize in triclinic space group P . The details are: compound I a = 11.941(6) ?, b = 12.154(7) ?, c = 13.006(7) ?, α = 63.124(8)°, β = 84.464(9)°, γ = 64.810(8)°, V = 1519.7(14) ?³, Z = 2, D _cal = 1.284 Mg m⁻³, and R = 0.0382 (wR = 0.0978); compound II a = 11.897(6) ?, b = 12.268(6) ?, c = 13.001(7) ?, α = 61.919(8)°, β = 83.480(8)°, γ = 64.676(7)°, V = 1504.0(14) ?³, Z = 2, D _cal = 1.333 Mg m⁻³, and R = 0.0422 (wR = 0.1049). The indole ring system in both the molecules I and II are not strictly planar and the dihedral angles formed by the pyrrole and benzo planes are 4.0(7)° and 3.5(8)°, respectively. The C–HO, C–Hπ and ππ types of interactions stabilize the molecules in the unit cell in addition to van der Waal's forces in I and II.     

Synthesis and X-ray analysis of 1-((1S)-phenylethyl)-azetidine-(2R)-piperidinamide

The crystal and molecular structure of a new azetidine-2-carboxylic amide derivative is described. The structure was solved by direct methods and refined by least squares methods toR1=0.0393 for 4264 reflections (withI>2(I)) The structure consists of two independent molecules which are chemically the same with slight differences in geometry. Crystal data: C₁₇H₂₄N₂O, monoclinic, space groupP2₁,a=8.3782(4),b=20.0342(13),c=9.7769(8) Å, =109.687(6)°,V=1545.1(2)ų,Z=4.     

Structure of (Z)-1-p-methoxyphenyltelluro-1,4-diphenyl but-1-en-3-yne

C₂₃H₁₈TeO,M _r=437.97, ,a=9.940(2),b=13.664(3),c=7.895(2) Å, =80.60(1), =69.71(2), =75.95(1)°,V=972.0(4) ų,Z=2,R=0.041 for 2668 observed reflections. The Te–C bond distances are 2.109(5)Å and the C–Te–C angle is 96.0(2)°. The phenyl rings are planar to within experimental accuracy, making dihedral angles of 64.6(2), 65.3(2) and 31.1(3)°.     

Crystal Structure of 2-{1-[(1-(2-Pyridinio)ethylidene)hydrazono]ethyl}pyridinium diperchlorate,the Product of Template Condensation in the Presence of Cr(III)

Abstract  In an attempt to synthesize a Cr(III) complex of 2′-[1-(2-pyridinyl)ethylidene]oxamohydrazide an azine product 2-{1-[(1-(2-pyridinio)ethylidene)hydrazono]ethyl}pyridinium diperchlorate was obtained by an electrophilic acyl substitution catalyzed by Cr(III). Its structure was determined by X-ray crystal analysis and showed significant changes in comparison to the corresponding unprotonated compound. The 2-{1-[(1-(2-pyridinio)ethylidene)hydrazono]ethyl}pyridinium diperchlorate crystallizes in the space group P2₁/n of the monoclinic crystal system with unit cell parameters a = 14.3809(3) ?, b = 24.1516(5) ?, c = 15.4471(3) ?, β = 99.930(2)°, V = 5284.74(19) ?³ and Z = 12, i.e. three molecules per asymmetric unit. Graphical Abstract  In the template condensation of the 2′-[1-(2-pyridinyl)ethylidene]oxamohydrazide in presence of the chromium(III) ion the 2-{1-[(1-(2-pyridinio)ethylidene)hydrazono]ethyl}pyridinium diperchlorate was obtained and characterized by NMR spectroscopy and X-ray crystallography. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users.     

Central Nervous System Drugs: Low Temperature X-ray Structures of (I) the Base 5-(2,3-Dichlorophenyl)-2,4-diamino-6-fluoromethyl-pyrimidine (4030W92) and (II) 5-(2,6-Dichlorophenyl)-1-H-2,4-diamino-6-methyl-pyrimidine methanesulphonic acid salt (227C89)

Abstract  The X-ray crystal structures of (I), the base 4030W92, 5-(2,3-dichlorophenyl)-2,4-diamino-6-fluoromethyl-pyrimidine, C₁₁H₉Cl₂FN₄, and (II) 227C89, the methanesulphonic acid salt of 5-(2,6-dichlorophenyl)-1-H-2,4-diamino-6-methyl-pyrimidine, C₁₁H₁₁Cl₂N₄ · CH₃O₃S, have been carried out at low temperature. A detailed comparison of the two structures is given. Structure (I) is non-centrosymmetric, crystallizing in space group P2₁ with unit cell a = 10.821(3), b = 8.290(3), c = 13.819(4) ?, β = 105.980(6)°, V = 1191.8(6) ?³, Z = 4 (two molecules per asymmetric unit) and density (calculated) = 1.600 mg/m³. Structure (II) crystallizes in the triclinic space group with unit cell a = 7.686(2), b = 8.233(2), c = 12.234(2) ?, α = 78.379(4), β = 87.195(4), γ = 86.811(4)°, V = 756.6(2) ?³, Z = 2, density (calculated) = 1.603 mg/m³. Final R indices [I > 2sigma(I)] are R1 = 0.0572, wR2 = 0.1003 for (I) and R1 = 0.0558, wR2 = 0.0982 for (II). R indices (all data) are R1 = 0.0983, wR2 = 0.1116 for (I) and R1 = 0.1009, wR2 = 0.1117 for (II). 5-Phenyl-2,4 diaminopyrimidine and 6-phenyl-1,2,4 triazine derivatives, which include lamotrigine (3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine), have been investigated for some time for their effects on the central nervous system. The three dimensional structures reported here form part of a newly developed data base for the detailed investigation of members of this structural series and their biological activities. Index Abstract  Low temperature X-ray structures of (I): the base 5-(2,3-dichlorophenyl)-2,4-diamino-6-fluoromethyl-pyrimidine (4030W92); and (II): 5-(2,6-dichlorophenyl)-1-H-2,4-diamino-6-methyl-pyrimidine methanesulphonic acid salt (227C89) are presented. Both drugs act on the central nervous system. (I) crystallizes in non-centrosymmetric space group P2₁ with two molecules A and B per asymmetric unit cell and (II) is triclinic in space group . The absolute configuration of (I) is determined.      

Molecular structure of 3-(3-oxo-bicyclo[2.2.1]hept-5-en-2-yl)-oxirane-2-carboxylic acid methyl ester

The crystal and molecular structure of an epoxy ester is described. The structure has been solved by vector search methods and refined by least squares methods toR ₁=0.0372 [I>2(I)]. The structure consists of two independent molecules in the asymmetric unit. These molecules are chemically the same. Crystal data: C₁₁H₁₂O₄, triclinic, space group ,a=10.324(3),b=10.553(7),c=10.869(5)Å, =61.77(4), =88.64(4), =88.16(6)°,V=1042.7(9)ų,Z=4.     

Crystal and molecular structure of: 5-(1-oxoethyl)-1-methyl-2-(5-bromo-6-methoxy-2-naphthyl)-6-oxabicyclo[3.2.1]octan-7-one and 5-(1-oxoethyl)-1-methyl-2-(5-bromo-6-methoxy-2-naphthyl)-6-oxabicyclo[3.2.1]octane

X-ray crystallographic studies of the two title compounds have shown that the molecules crystallize in the same triclinic space group, , with very similar cell dimensions. For C₂₁H₂₁BrO₄,a=12.056(5),b=13.206(5),c=7.595(3)Å, =90.38(3), =106.07(3) and =124.42(3)° and for C₂₁H₂₃BrO₃,a=12.076(6),b=13.090(5),c=7.490(3)Å, =92.65(5), =104.90(5) and =124.55(5)°. Both compounds possess the oxabicyclo[3.2.1]octane bridged ring system and differ only at the carbon to the ring oxygen where the Csp³ in the ether is replaced by Csp²=O in the lactone. Both cyclohexane rings adopt distorted chair conformations and the lactone and ether rings approximate closely to the envelope conformation. The bromine substituent at C(4) results in distortion of the naphthalene ring. Both molecules pack with the naphthalene rings parallel to each other with interplanar spacings of 3.71 Å in the ether and 3.66Å in the lactone.     

Crystal structures of ester derivatives of 2,6-bis(1-pyrrolidinylmethyl)-4-benzamidophenol antiarrhythmic agents

The N atoms in both of the pyrrolidine rings in the title compounds are protonated which prevents the formation of an intramolecular hydrogen bond between the phenol OH group and the ring N atom. This hydrogen bond is thought to be important for maintaining the active shape of these drugs. The positions of the pyrrolidine rings are determined by a chain of hydrogen bonds which link the N⁺–H through the Cl^– back to portions of the same molecule. In both molecules, the carbonyl bond of the ester substituent is aligned parallel to the carbonyl bond of the central amide. The benzanilide fragment is flattened relative to the common conformation found in tabulated structures. Extensive hydrogen bonding is observed due to the presence of solvent and chloride ions. Compound1, 2,6-bis(1-pyrrolidinylmethyl)-4-(4-carboethoxybenzamido)phenol, crystallizes as the dihydrochloride methanol hydrate in the monoclinic space group C2/c with 8 molecules per unit cell and cell constants:a=20.3013,b=11.296(2),c=24.901(5)Å, =93.19(1)°, 4945 unique reflections, 2946 observed,R=0.071. Compound2, 2,6-bis[1-pyrrolidinylmethyl-4-[4-(2-carboethoxyethyl)benzamido]phenol, crystallizes as the dihydrochloride salt in the monoclinic space group P2₁/c with 4 molecules per unit cell anda=12.903(3),b=16.430(4),c=13.731(2)Å, =103.64(2)°, 5712 unique reflections, 2449 observed,R=0.057.     

X-ray diffraction structure of the pentamethylcyclopentadienylruthenium complex Cp*Ru(NO)(ox)

The reaction between the pentamethylcyclopentadienyl complex Cp^*Ru(NO)Cl₂ and oxalic acid in methanolic KOH affords the corresponding oxalate compound Cp^*Ru(NO)(ox) in moderate yield. The title complex has been isolated and characterized in solution by IR and NMR (¹H and¹³C) spectroscopy, and the solid-state structure has been established by X-ray diffraction analysis, which confirmed the presence of the chelating oxalate ligand in Cp^*Ru(NO)(ox). Cp^*Ru(NO)(ox) crystallizes in the triclinic space group ,a=7.0875(9) Å,b=8.589(2) Å,c=12.784(4) Å, =73.58(2)°, =88.93(2)°, =66.86(2)°,V=682.7(8) ų,Z=2,d _calc=1.724 g·cm^–3; R=0.053, R_w=0.071 for 1561 observed reflections withI>3(I).     

Structural Conformation of a Novel 1-Benzhydrylpiperazine Derivative: 1-Benzhydryl-4-(toluene-4-sulfonyl)-piperazine

Abstract  The title compound 1-benzhydryl-4-(toluene-4-sulfonyl)-piperazine was synthesized and the structure was investigated by X-ray crystallography. The title compound, C₂₄H₂₆N₂O₂S crystallizes in the monoclinic crystal class in the space group P2₁/c with cell parameters a = 13.5800(10) ?, b = 8.9630(7) ?, c = 18.9040(10) ?, β = 106.851(3)°, Z = 4 and V = 2202.1(3) ?³. The structure has been solved by direct methods and refined to R ₁ = 0.0468 for 3174 observed reflections I > 2σ(I). The structure reveals that the piperazine ring is in a chair conformation. The geometry around the S atom is a distorted tetrahedron. Graphical Abstract  The title compound 1-benzhydryl-4-(toluene-4-sulfonyl)-piperazine was synthesized and the structure was investigated by X-ray crystallography. The title compound, C₂₄H₂₆N₂O₂S crystallizes in the monoclinic crystal class in the space group P2₁/c with cell parameters a = 13.5800(10) ?, b = 8.9630(7) ?, c = 18.9040(10) ?, β = 106.851(3)°, Z = 4 and V = 2202.1(3) ?³. The structure has been solved by direct methods and refined to R ₁ = 0.0468 for 3174 observed reflections I > 2σ(I). The structure reveals that the piperazine ring is in a chair conformation. The geometry around the S atom is a distorted tetrahedron.

Crystal structures of three 1-arylpropane-1,2-diol 2-aryl ether derivatives and the acetate of 2,6-dimethoxy-4-(1-(E)-propenyl)phenol

The crystal structures ofthreo-2-[2,6-dimethoxy-4-(1-(Z)-propenyl)phenoxy]-1-(4-hydroxy-3,5-dimethoxyphenyl)-1-propanol (7b),threo-2-(2,6-dimethoxy-4-propylphenoxy)-1-(3,4-5-trimethoxyphenyl)-1-propanol (7c), the diacetate oferythro-2-[2,6-dimethoxy-4-(1-(Z)-propenyl)phenoxy]-1-(4-hydroxy-3,5-dimethoxyphenyl)-1-propanol (8d) and the acetate of 2,6-dimethoxy-4-(1-(E)-propenyl)phenol (9) have been determined by single-crystal X-ray diffraction methods;7b,7c, and8d are structurally closely related to a class of optically-active neolignans of 1-arylpropane-1,2-diol 2-aryl ether type occurring in plant extracts. The reflection intensities were recorded at room temperature for7b and8d, at -140°C for7c and at -120°C for9. Compound7b crystallized as needles in the orthorhombic space groupPna2₁ witha=27.055(3),b=11.850(8),c=6.717(4)Å andZ=4.R became 0.041 for 1792 observed [I>3(I)] reflections used in the refinement of the structure. Compound7c crystallized as prisms in the monoclinic space groupP2₁/a witha=12.565(4),b=13.96(1),c=12.846(7)Å,=93.86(3)° andZ=4. The refinement gaveR=0.051 for 2101 observed [I>3(I)], unique reflections. Compound8d crystallized as prisms in the monoclinic space groupP2₁/n witha=13.182(4),b=8.518(5),c=23.322(5)Å,=106.12(2)° andZ=4. The finalR-valuebecame 0.042 for 2131 observed [I>3(I)], unique reflections. Compound9 crystallized as prisms in the orthorhombic space groupPca2₁ witha=18.216(4),b=9.483(3),c=7.416(2)Å andZ=4. TheR-value became 0.038 for 1502 observed [I>3(I)], unique reflections. The crystals of7b are stabilized by moderately strong hydrogen bonds. All the 1-arylpropane-1,2-diol 2-aryl ethers examined adopted conformations in which the aromatic groups tend to be as remote as possible. Observed double bond lengths in the propenyl groups of the compounds examined (1.30 Å) deviate significantly from the expected value (1.34 Å). The cause of this discrepancy is discussed.     

4- and 5-nitroindane

Mononitration of indane produces a mixture of 4- and 5- nitroindanes. Crystallization from mixtures occurs after distillation improves composition of a major component to above 80%. 4-Nitroindane: triclinic, space group (#2),a=7.332(4) Å,b=8.304(4) Å,c=8.358(4) Å, =61.43(4)°, =67.60(4)°, =70.15(4)°,V=405.4(4) ų,Z=2. Non-H-atoms are nearly planar, aliphatic H's are eclipsed. 5-Nitroindane: monoclinic, space groupP2₁/c (#14),a=10.946(8) Å,b=15.643(10) Å,c=9.415(6) Å, =92.34(5)°,V=1611(2) ų,Z=8. Non-H-atoms in the two molecules differ in torsion of the nitro group with respect to indane and fold of the nonbenzylic methylene group. Semiempirical calculations (PM3) suggest that distorsion from planarity may be associated with the two lowest energy vibrational modes. Uv, ir, ms, proton, and¹³C-nmr spectra are correlated with the solid state structures.     

2-(1-Methyl-1H-indol-3-ylmethylene)-1-aza-bicyclo[2.2.2] octan-3-one: Acid-catalyzed isomerization of the Z isomer to the E isomer

Crystals of (Z)-2-(1-methyl-1H-indol-3-ylmethylene)-1-aza-bicyclo[2.2.2]octan-3-one (I) were obtained from a condensation reaction of 1-methyl-1H-indole-3-carboxaldehyde with 1-aza-bicyclo[2.2.2]octan-3-one and subsequent crystallization of the product from methanol. The isomeric (E)-2-(1-methyl-1H-indol-3-ylmethylene)-1-aza-bicyclo[2.2.2] octan-3-one hydrochloride (II) was obtained by treating a methanolic solution of I with a 1M solution of hydrogen chloride diethyl ether, followed by crystallization of resultant product from methanol. Crystal data: I, is monoclinic, P2₁, a = 5.7440(10), b = 11.102(2), c = 10.708(2) Å, = 91.751(10)°, and V = 682.5(2) ų with Z = 2, for D _cal= 1.296 mg/m³ and II, is monoclinic, P2₁/c, a = 8.8510(2), b = 17.4990(5), c = 20.4300(5) Å, = 101.3620(12)°, V = 3102.26(14) with Z = 8, for D _cal= 1.316 mg/m³.     

Crystal structures of two azo compounds, 2-methyl-2-(4-bromphenylazo)-1,3-indandione and 2-methyl-2-(4-ethoxyphenylazo)-1,3-indandione

In the two title compounds, the 2-methyl-1,3-dioxoindan-2-yl and 4-(brom; ethoxy) phenyl groups aretrans with respect to one another. The phenyl ring and the azo group are not coplanar in the two molecules. The five-membered rings of the two compounds adopt an envelope conformation. The crystallographic parameters are as follows: 2-Methyl-2-(4-bromphenylazo)-1,3-indandione (I): monoclinic, P2₁/a witha=8.098(2),b=14.442(2),c=12.554(1)Å, =100.55(2)^o, andD _calc=1.58 g cm^–3 forZ=4; 2-methyl-2-(4-ethoxyphenylazo)-1, 3-indandione (II): monoclinic, P2₁/a witha=8.258(2),b=14.449(1),c=13.559(2)Å, =101.19(1)^o, andD _calc=1.29 g cm^–3 forZ=4.